Company / Return on Equity (ROE)
LIFECORE BIOMEDICAL, INC. \DE\ Return on Equity (ROE) History
FY2012-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
4.2%
FY2019
5-year range
-4.6% / 10.3%
FY2015-FY2019
Trend
+190.9%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Equity (ROE) returned to growth in FY2019 after 3 years of decline, reaching 4.2%.
Based on SEC 10-K filings.
4.2% in FY2019 with a 5-year CAGR of -2.1%.
Improved from 1.1% to 4.2% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -4.9pp
- 5-Year Change
- -2.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2019, return on equity (roe) increased 190.9% year-over-year.
- Peak return on equity (roe) was recorded in FY2015.
- Lowest return on equity (roe) in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2019 | 4.2% | +190.9% |
| FY2018 | -4.6% | -511.6% |
| FY2017 | 1.1% | -87.7% |
| FY2016 | 9.1% | -12.1% |
| FY2015 | 10.3% | +65.4% |
| FY2014 | 6.3% | +185.4% |
| FY2013 | 2.2% | -17.7% |
| FY2012 | 2.7% | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026